Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial

Published:2007-01 Issue:1 Volume:61 Page:14-24
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Wolinsky Jerry S.,Narayana Ponnada A.,O'Connor Paul,Coyle Patricia K.,Ford Corey,Johnson Kenneth,Miller Aaron,Pardo Lillian,Kadosh Shaul,Ladkani David,

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference26 articles.

1. Defining the clinical course of multiple sclerosis: results of an international survey;Lublin;Neurology,1996

2. Multiple sclerosis;Noseworthy;N Engl J Med,2000

3. The diagnosis of primary progressive multiple sclerosis;Wolinsky;J Neurol Sci,2003

4. Primary progressive multiple sclerosis: increasing clarity but many unanswered questions;McDonnell;J Neurol Sci,2002

Cited by 363 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-09-10

2. Selecting informative patients for phase 2 progressive trials in MS: Design considerations for phase 2 clinical trials in progressive MS;Multiple Sclerosis Journal;2024-09-08

3. The cost-utility analysis of adding ocrelizumab to the treatment plan for primary progressive multiple sclerosis in Iran;Expert Review of Pharmacoeconomics & Outcomes Research;2024-08-08

4. Therapeutic lag: Is treatment effect delayed in progressive MS?;Multiple Sclerosis Journal;2024-04-14

5. Disease-modifying therapy in progressive multiple sclerosis: a systematic review and network meta-analysis of randomized controlled trials;Frontiers in Neurology;2024-03-11